1. Home
  2. BMR vs LSTA Comparison

BMR vs LSTA Comparison

Compare BMR & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beamr Imaging Ltd.

BMR

Beamr Imaging Ltd.

HOLD

Current Price

$1.83

Market Cap

28.1M

Sector

Technology

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$3.18

Market Cap

28.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMR
LSTA
Founded
2009
1980
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Misc Health and Biotechnology Services
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.1M
28.9M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
BMR
LSTA
Price
$1.83
$3.18
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
72.0K
31.8K
Earning Date
02-26-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.42
EPS
N/A
N/A
Revenue
N/A
$35,283,868.00
Revenue This Year
$1.20
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
56.90
52 Week Low
$1.26
$1.81
52 Week High
$4.32
$5.07

Technical Indicators

Market Signals
Indicator
BMR
LSTA
Relative Strength Index (RSI) 52.99 40.29
Support Level $1.89 $3.02
Resistance Level $1.97 $3.41
Average True Range (ATR) 0.11 0.12
MACD -0.02 0.05
Stochastic Oscillator 60.99 46.64

Price Performance

Historical Comparison
BMR
LSTA

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd provides content-adaptive video compression solutions for human viewing and machine vision. The company is trusted by technology companies such as NVIDIA and Amazon Web Services, and serves media companies including Netflix, Paramount, and JioHotstar. Using Emmy-winning patented technology, its solutions help deliver media content with high quality while reducing storage and delivery costs. Its customers include over-the-top content distributors, video streaming platforms, and Hollywood studios that use its products to store, distribute, and monetize video and images across devices. The company operates in the United States, Israel, and the rest of the world, with the United States generating maximum revenue.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: